Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07832032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine

Study acronym: BioM
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
There are still no reliable biomarkers for migraine; the diagnosis is based on symptomatology, and the pathogenesis remains largely a mystery. However, the past decade has seen a shift from a trial-and-error treatment strategy to a more biologically driven approach using CGRP-targeted drugs (gepants) and monoclonal antibodies (mAbs). This study aims to profile levels of perivascular and hypothalamic neuropeptides, as well as microRNA (miRNA) and neurotrophins, in individuals with migraine. The study builds on a previous pilot investigation (Neuropeptides during migraine attacks, REK 808581).
Trial Details
NCT Number NCT07832032
Lead Sponsor Nordlandssykehuset HF
Collaborators: Norwegian University of Science and Technology
Conditions
(from sponsor)		 Migraine
Related terms Diabetes Insipidus, Migraine Disorders
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov